Nuvei to Acquire Payoneer for $2.75 Billion in Major Cross-Border Payments Deal
The deal will create a leading global payments platform combining payment acceptance and cross-border payouts across 190+ countries.
NOTRELOAD AI
Elicio Stock Falls After Phase 2 Pancreatic Cancer Trial Misses Primary Endpoint
Elicio stock plunged after Phase 2 failed main goal, but showed cancer benefit in selected patients.
Fox Bets Big on Streaming with $22 Billion Roku Buyout
The combination creates a major U.S. streaming and live TV platform.
American Express Expands Dining Network with $700 Million TheFork Acquisition
The deal expands Amex’s dining network to 75,000 venues across Europe and strengthens its presence in the region.
Twist Bioscience Stock Surges Toward $1 Billion Goal as Canaccord Joins Bullish Chorus
Canaccord is bullish on Twist Bioscience, citing AI-driven DNA tech growth, strong revenue gains, and upside to $90 target.
Traws Pharma Puts Phase 2 Influenza Trial on Hold After UK Regulator Feedback
Traws Pharma shares fell after delaying its Phase 2 human influenza challenge study due to negative feedback from the UK’s MHRA. The company is now advancing backup flu antiviral candidates.